Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

London pre-open: Stocks seen lower; NatWest in focus

(Sharecast News) - London stocks were set for a weaker open on Friday following a downbeat session on Wall Street, with earnings from NatWest in focus. The FTSE 100 was called to open 24 points lower at 7,668.

CMC Markets analyst Michael Hewson said: "As far as today's price action is concerned, the late decline in the US looks set to translate into a weaker European open, even though confidence is growing that the Fed is more or less done when it comes to its rate hiking cycle.

"Nonetheless, investors will be looking for further evidence of this with the latest core PCE deflator, as well as personal spending and income data for June, later this afternoon to support the idea of weaker inflation.

"Anything other than a PCE Core Deflator slowdown to 4.2% from 4.6%, could keep the prospect of a 25bps September hike on the table for a few weeks more. Both personal spending and income data are expected to improve to 0.4% and 0.5% respectively."

In UK corporate news, NatWest reported better-than-expected interim profits only days after it was rocked by the resignation of chief executive Alison Rose over the leaking of details of hard-right former political party leader Nigel Farage.

The bank posted pre-tax profit of £3.6bn, up from £2.6bn a year earlier and better than the £3.3bn estimated by analysts. It also announced a £500m share buyback.

Elsewhere, AstraZeneca reported a strong first half, driven by successful launches and effective commercial execution.

Excluding Covid-19 medicines, total revenue and product sales grew by 16% and 15%, respectively. The company also saw a 21% increase in core earnings per share, reaching $4.07, and maintained its interim dividend at 93 cents. AstraZeneca reaffirmed its full-year guidance for both total revenue and core earnings per share.

Share this article

Related Sharecast Articles

London open: Stocks gain as investors mull Rightmove data; inflation eyed
(Sharecast News) - London stocks edged higher early trade on Monday as investors mulled the latest UK house price figures and looked ahead to key inflation data later in the week.
London pre-open: Stocks seen up as investors mull Rightmove data
(Sharecast News) - London stocks were set to rise at the open on Monday as investors mulled the latest UK house price figures.
London close: Stocks recoup some earlier losses
(Sharecast News) - London stocks remained in negative territory by Friday's close, although they managed to recoup some of the losses seen earlier in the session as Wall Street opened with positive momentum.
London midday: FTSE stays down; Auto Trader hit by downgrade
(Sharecast News) - London stocks were still in the red by midday on Friday, having taken their opening cue from a downbeat close on Wall Street.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.